Snake venom phospholipases A2 (PLA2) show a remarkable functional diversity. Among their toxic activities, some display the ability to cause rapid necrosis of skeletal muscle fibers, thus being myotoxic PLA2s. Besides myotoxicity, these enzymes evoke conspicuous inflammatory and nociceptive events in experimental models. Local inflammation and pain are important characteristics of snakebite envenomations inflicted by viperid and crotalid species, whose venoms are rich sources of myotoxic PLA 2s. Since the discovery that mammalian PLA2 is a key enzyme in the release of arachidonic acid, the substrate for the synthesis of several lipid inflammatory mediators, much interest has been focused on this enzyme in the context of inflammation. The mechanisms involved in the proinflammatory action of secretory PLA2s are being actively investigated, and part of the knowledge on secretory PLA2 effects has been gained by using snake venom PLA2s as tools, due to their high structural homology with human secretory PLA2s. The inflammatory events evoked by PLA2s are primarily associated with enzymatic activity and to the release of arachidonic acid metabolites. However, catalytically inactive Lys49 PLA2s trigger inflammatory and nociceptive responses comparable to those of their catalytically active counterparts, thereby evidencing that these proteins promote inflammation and pain by mechanisms not related to phospholipid hydrolysis nor to mobilization of arachidonic acid. These studies have provided a boost to the research in this field and various approaches have been used to identify the amino acid residues and the specific sites of interaction of myotoxic PLA2s with cell membranes potentially involved in the PLA2-induced inflammatory and nociceptive effects. This work reviews the proinflammatory and nociceptive effects evoked by myotoxic PLA2s and their mechanisms of action. © 2004 Published by Elsevier Ltd.428947962Abbott, F.V., Guy, E.R., Effects of morphine, pentobarbital and amphetamine on formalin-induced behaviours in infant rats: Sedation versus specific suppression of pain (1995) Pain, 62, pp. 303-312Abbott, F.V., Hong, Y., Blier, P., Persisting sensitization of the behavioural response to formalin-induced injury in the rat through activation of serotonin 2A receptors (1997) Neuroscience, 77, pp. 575-584Aderem, A., Underhill, D.M., Mechanisms of phagocytosis in macrophages (1999) Annu. Rev. Immunol., 17, pp. 523-593Akopian, A.N., Sivilotti, L., Wood, J.N., A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons (1996) Nature, 379, pp. 257-262Alam, R., Lett-Brown, M.A., Forsythe, P.A., Anderson-Walters, D.J., Kenamore, C., Kormos, C., Monocyte chemotactic and activating factor (MCAF) is a potent histamine-releasing factor for basophils (1992) J. Clin. Invest., 89, pp. 723-728Allen, A.C., Gammon, C.M., Ousley, A.H., McCarthy, K.D., Morell, P., Bradykinin stimulates arachidonic acid release through the sequential actions of an sn-1 diacylglycerol lipase and a monoacylglycerol lipase (1992) J. Neurochem., 58, pp. 1130-1139Antunes, E., Mariano, M., Cirino, G., Levi, S., De Nucci, G., Pharmacological characterization of polycation-induced rat hind-paw oedema (1990) Br. J. Pharmacol., 101 (4), pp. 986-990Appleton, I., Tomlinson, A., Willoughby, D.A., Induction of cyclo-oxygenase and nitric oxide synthase in inflammation (1996) Adv. Pharmacol., 35, pp. 27-79Arroyo, O., Rojas, G., Gutiérrez, J.M., Envenenamiento por mordedura de serpiente en Costa Rica en 1996: Epidemiología y consideraciones clínicas (1996) Acta Médica Costarricense, 41, pp. 23-29Balsinde, J., Balboa, M.A., Dennis, E.A., Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A 2 (1998) Proc. Natl. Acad. Sci. USA, 95 (14), pp. 7951-7956Beghini, D.G., Toyama, M.H., Hyslop, S., Sodek, L.C., Novello, J.C., Marangoni, S., Enzymatic characterization of a novel phospholipase A2 from Crotalus durissus cascavella rattlesnake (Maracamboia) venom (2000) J. Protein Chem., 19 (8), pp. 679-684Bomalaski, J.S., Lawton, P., Browning, J.L., Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints (1991) J. Immunol., 146, pp. 3904-3910Mezey, E., Toth, Z.E., Cortright, D.N., Arzubi, M.K., Krause, J.E., Elde, R., Guo, A., Szallasi, A., Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 3655-3660Millan, M.J., The induction of pain: An integrative review (1999) Prog. Neurobiol., 57, pp. 1-164Mizumura, K., Minagawa, M., Koda, H., Kumazawa, T., Influence of histamine on the bradykinin response of canine testicular polymodal receptors in vitro (1995) Inflamm. Res., 44, pp. 376-378Moore, P.A., Hersh, E.V., Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice (2001) J. Am. Dent. Assoc., 132, pp. 451-456Moreno, J.J., Ferrer, X., Ortega, E., Carganico, G., PLA2 induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action (1992) Agents Actions, 36, pp. 258-263Mukherjee, A.B., Miele, L., Pattabiraman, N., Phospholipase A2 enzymes: Regulation and physiological role (1994) Biochem. Pharmacol., 48, pp. 1-10Murakami, M., Kambe, T., Shimbara, S., Yamamoto, S., Kuwata, H., Kudo, I., Functional association of type IIA secretory phospholipase A2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway (1999) J. Biol. Chem., 274, pp. 29927-29936Nagai, H., Sakamoto, T., Kondo, M., Miura, T., Inagaki, N., Koda, A., Extracellular phospholipase A2 and histamine release from rat peritoneal mast cells (1991) Int. Arch. Allergy Appl. Immunol., 96 (4), pp. 311-316Nair, X., Nettleton, D., Clever, D., Tramposch, K.M., Ghosh, S., Franson, R.C., Swine as a model of skin inflammation. Phospholipase A 2-induced inflammation (1993) Inflammation, 17 (2), pp. 205-215Coleman, J.W., Holgate, S.T., Church, M.K., Godfrey, R.C., Immunoglobulin e decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells (1981) Biochem. J., 198, pp. 615-619Nakae, H., Endo, S., Inada, K., Yamashita, H., Yamada, Y., Takakuwa, T., Kasai, T., Uchida, K., Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns (1995) Burns, 21, pp. 422-426Bonta, I.L., Vargaftig, B.B., Bohm, G.M., Handbook of experimental pharmacology (1979) Snake Venoms, 52, pp. 629-683. , Lee C.YNakamura, M., Ferreira, S.H., A peripheral sympathetic component in inflammatory hyperalgesia (1987) Eur. J. Pharmacol., 135, pp. 145-153Needham, L., Hellewell, P.G., Williams, T.J., Gordon, J.L., Endothelial functional responses and increased vascular permeability induced by polycations (1988) Lab. Invest., 59 (4), pp. 538-548Nevalainen, T.J., Haapamaki, M.M., Gronroos, J.M., Roles of secretory phospholipases A2 in inflammatory diseases and trauma (2000) Biochim. Biophys. Acta, 1488, pp. 83-90Núñez, C.E., Angulo, Y., Lomonte, B., Identification of the myotoxic site of the Lys49 phospholipase A 2 from Agkistrodon piscivorus piscivorus snake venom: Synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities (2001) Toxicon, 39, pp. 1587-1594Ohsaka, A., Hemorrhagic, necrotizing and edema-forming effects of snake venoms (1979) Handbook of Experimental Pharmacology. Snake Venoms, 52, pp. 480-546. , C.Y. Lee. Berlin: SpringerOshima-Franco, Y., Leite, G.B., Silva, G.H., Cardoso, D.F., Hyslop, S., Giglio, J.R., Da Cruz-Hofling, M.A., Rodrigues-Simioni, L., Neutralization of the pharmacological effects of bothropstoxin-I from Bothrops jararacussu (jararacucu) venom by crotoxin antiserum and heparin (2001) Toxicon, 39 (10), pp. 1477-1485Ownby, C.L., Selistre-De-Araujo, H.S., White, S.P., Fletcher, J.E., Lysine 49 phospholipase A2 proteins (1999) Toxicon, 37, pp. 411-445Ozaktay, A.C., Kallakuri, S., Cavanaugh, J.M., Phospholipase A2 sensitivity of the dorsal root and dorsal root ganglion (1998) Spine, 23, pp. 1297-1306Cunha, F.Q., Lorenzetti, B.B., Poole, S., Ferreira, S.H., Interleukin-8 as a mediator of sympathetic pain (1991) Br. J. Pharmacol., 104, pp. 765-767Padawer, J., Cytological studies on normal and surviving mast cells in vitro (1970) Am. J. Anat., 127 (2), pp. 159-179Page, I.H., The discovery of serotonin (1976) Perspect. Biol. Med., 20, pp. 1-8Bowton, D.L., Seeds, M.C., Fasano, M.B., Goldsmith, B., Bass, D.A., Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics (1997) Am. J. Resp. Crit. Care Med., 155, pp. 421-425Parada, C.A., Vivancos, G.G., Tambeli, C.H., De Queiroz Cunha, F., Ferreira, S.H., Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 2923-2928Páramo, L., Lomonte, B., Pizarro-Cerda, J., Bengoechea, J.A., Gorvel, J.P., Moreno, E., Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A 2 from Bothrops asper snake venom - Synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region (1998) Eur. J. Biochem., 253, pp. 452-461Pereira, M.F., Novello, J.C., Cintra, A.C., Giglio, J.R., Landucci, E.T., Oliveira, B., Marangoni, S., The amino acid sequence of bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (Jararacucu) venom with low phospholipase A2 activity (1998) J Protein Chem., 17, pp. 381-386Pinheiro, R.M., Campos, M.M., Calixto, J.B., Analysis of the mechanisms involved in the inflammatory response induced by des-Arg9-bradykinin in the rat pleural cavity (2001) Inflamm. Res., 50, pp. 570-576Piperno, M., Hellio Le Graverand, M.P., Reboul, P., Mathieu, P., Tron, A.M., Perrin, G., Peschard, M.J., Vignon, E., Phospholipase A2 activity in herniated lumbar discs. Clinical correlation and inhibition by piroxicam (1997) Spine, 22, pp. 2061-2065Poole, S., Lorenzetti, B.B., Cunha, J.M., Cunha, F.Q., Ferreira, S.H., Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia (1999) Br. J. Pharmacol., 126, pp. 649-656Proud, D., Kaplan, A.P., Kinin formation: Mechanisms and role in inflammatory disorders (1988) Annu. Rev. Immunol., 6, pp. 49-83Cunha, F.Q., Poole, S., Lorenzetti, B., Ferreira, S.H., The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia (1992) Br. J. Pharmacol., 107, pp. 660-664Proud, D., Togias, A., Naclerio, R.M., Crush, S.A., Norman, P.S., Lichtenstein, L.M., Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen (1983) J. Clin. Invest., 72, pp. 1678-1685Pruzanski, W., Saito, S., Stefanski, E., Vadas, P., Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes (1991) Inflammation, 15, pp. 127-135Rabinovitch, M., De Stefano, M.J., Macrophage spreading in vitro. I. Inducers of spreading (1973) Exp. Cell. Res., 77, pp. 323-334Brain, S.D., Whittle, B.J.E., Action of phospholipase A2 on mast cell histamine release and paw oedema in rat (1977) Br. J. Pharmacol., 59. , 440 ppReasbeck, P.G., Rice, M.L., Reasbeck, J.C., Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery (1982) Lancet, 2, pp. 115-118Regoli, D.C., Marceau, F., Lavigne, J., Induction of B1 receptors for kinins in the rabbit by a bacterial lipopolysaccharide (1981) Eur. J. Pharmacol., 71, pp. 105-115Ren, K., Dubner, R., NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw (1993) Neurosci. Lett., 163, pp. 22-26Richardson, B.P., Engel, G., The pharmacology and function of 5-HT3 receptors (1986) Trends Neurosci., 9, pp. 424-427Riedel, W., Neeck, G., Nociception, pain, and antinociception: Current concepts (2001) J. Rheumatol., 60, pp. 404-415Rizzo, M.T., Nguyen, E., Aldo-Benson, M., Lambeau, G., Secreted phospholipase A2 induces vascular endothelial cell migration (2000) Blood, 96, pp. 3809-3815Cury, Y., Chacur, M., Longo, I., Lomonte, B., Gutiérrez, J.M., (2002) Structural Mechanisms of Pain Induced by Asp49 and Lys49 Myotoxic Phospholipases A2 (PLA2) Isolated from Bothrops Asper Venom. IASP (International Association for the Study on Pain), 10th World Congress on Pain, Abstracts, , p. 150Rojas, G., Gutiérrez, J.M., Gené, J.A., Gómez, M., Cerdas, L., Neutralización de las actividades tóxicas y enzimáticas de cuatro venenos de serpientes de Guatemala y Honduras por el antiveneno polivalente producido en Costa Rica (1987) Rev. Biol. Trop., 35, pp. 59-67Rosenberg, P., Pharmacology of phospholipase A2 from snake venoms (1979) Handbook of Experimental Pharmacology. Snake Venoms, 52, p. 403. , C.Y. Lee. Berlin: SpringerRoy, M.L., Narahashi, T., Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons (1992) J. Neurosci., 12, pp. 2104-2111Ryan, G.B., Majno, G., Antiinflammation. A review (1977) Am. J. Pathol., 86, pp. 183-276Caffrey, J.M., Eng, D.L., Black, J.A., Waxman, S.G., Kocsis, J.D., Three types of sodium channels in adult rat dorsal root ganglion neurons (1992) Brain Res., 592, pp. 283-297Saal, J.A., Saal, J.S., Herzog, R.J., The natural history of lumbar intervertebral disc extrusions treated nonoperatively (1990) Spine, 15, pp. 683-686Saegusa, H., Matsuda, Y., Tanabe, T., Effects of ablation of N- and R-type Ca2+channels on pain transmission (2002) Neurosci. Res., 43, pp. 1-7Samuelsson, B., Dahlen, S.E., Lindgren, J.A., Rouzer, C.A., Serhan, C.N., Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects (1987) Science, 237, pp. 1171-1176Sann, H., Jancso, G., Rossler, W., Pierau, F.K., Reduction of sub stance P binding sites in the spinal dorsal horn after perineural capsaicin treatment in the rat (1995) Neurosci. Lett., 190, pp. 151-154Santana, A., Hyslop, S., Antunes, E., Mariano, M., Bakhle, Y.S., De Nucci, G., Inflammatory responses induced by poly-L-arginine in rat lungs in vivo (1993) Agents Actions, 39 (3-4), pp. 104-110Dahinden, C.A., Geiser, T., Brunner, T., Von Tscharner, V., Caput, D., Ferrara, P., Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine (1994) J. Exp. Med., 79, pp. 751-756Schroder, T., Kivilaakso, E., Kinnunen, P.K., Lempinen, M., Serum phospholipase A2 in human acute pancreatitis (1980) Scand. J. Gastroenterol., 15, pp. 633-636Schwartz, L.B., Mast cells: Function and contents (1994) Curr. Opin. Immunol., 6 (1), pp. 91-97Scott, K.F., Bryant, K.J., Bidgood, M.J., Functional coupling and differential regulation of the phospholipase A2-cyclooxygenase pathways in inflaCalderón, L., Lomonte, B., Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom (1998) Arch. Biochem. Biophys., 358, pp. 343-350Calderón, L., Lomonte, B., Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129 (1999) Toxicon, 37, pp. 683-687Cao, Y.Q., Mantyh, P.W., Carlson, E.J., Gillespie, A.M., Epstein, C.J., Basbaum, A.I., Primary afferent tachykinins are required to experience moderate to intense pain (1998) Nature, 392, pp. 390-394Castro, R.C., Landucci, E.C., Toyama, M.H., Giglio, J.R., Marangoni, S., De Nucci, G., Antunes, E., Leucocyte recruitment induced by type II phospholipases A2 into the rat pleural cavity (2000) Toxicon, 38 (12), pp. 1773-1785Chacur, M., Picolo, G., Gutiérrez, J.M., Teixeira, C.F.P., Cury, Y., Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom (2001) Toxicon, 39, pp. 1173-1181Chacur, M., Longo, I., Picolo, G., Gutiérrez, J.M., Lomonte, B., Guerra, J.L., Teixeira, C.F., Cury, Y., Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: Pharmacological mediation and molecular determinants (2003) Toxicon, 41, pp. 667-678Chandrasekharan, N.V., Dai, H., Roos, K.L.T., Evanson, N.K., Tomsik, J., Elton, T.S., Simmons, D.L., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression (2002) Proc. Natl. Acad. Sci. USA, 99, pp. 13926-13931Damerau, B., Lege, L., Oldigs, H.D., Vogt, W., Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase a of cobra venom (1975) Naunyn Schmiedebergs Arch. Pharmacol., 287, pp. 141-156Chaves, F., León, G., Alvarado, V.H., Gutiérrez, J.M., Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo) (1998) Toxicon, 36, pp. 1861-1869Chen, C., Cavanaugh, J.M., Ozaktay, A.C., Kallakuri, S., King, A.L., Effects of phospholipases A2 on lumbar nerve root structure and function (1997) Spine, 22, pp. 1057-1064Choi, S.H., Sakamoto, T., Fukutomi, O., Inagaki, N., Matsuura, N., Nagai, H., Koda, A., Pharmacological study of phospholipase A2-induced histamine release from rat peritoneal mast cells (1989) J. Pharmacobiodyn., 12 (9), pp. 517-522Cintra, A.C.O., Marangoni, S., Oliveira, B., Giglio, J.R., Bothropstoxin-I: Amino acid sequence and function (1993) J. Protein Chem., 12, pp. 57-64Cirino, G., Peers, S.H., Wallace, J.L., Flower, R.J., A study of phospholipase A2-induced oedema in rat paw (1989) Eur. J. Pharmacol., 166, pp. 505-510Cirino, G., Cicala, C., Sorrentino, L., Maiello, F.M., Browning, J.L., Recombinant secreted nonpancreatic phospholipase A2 induces a synovitis-like inflammation in the rat air pouch (1994) J. Rheumatol., 21 (5), pp. 824-829Coderre, T.J., Melzack, R., The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury (1992) J. Neurosci., 12, pp. 3665-3670Colburn, R.W., Rickman, A.J., Deleo, J.A., The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behaviour (1999) Exp. Neurol., 157, pp. 289-304Daniele, J.J., Bianco, I.D., Delgado, C., Carrillo, D.B., Fidelio, G.D., A new phospholipase A2 isoform isolated from Bothrops neuwiedii (Yarara chica) venom with novel kinetic and chromatographic properties (1997) Toxicon, 35 (8), pp. 1205-1215Dennis, E.A., Diversity of group types, regulation, and function of phospholipase A2 (1994) J. Biol. Chem., 269 (18), pp. 13057-13060Devillier, P., Renoux, M., Giroud, J.P., Regoli, D., Peptides and histamine release from rat peritoneal mast cells (1985) Eur. J. Pharmacol., 117, pp. 89-96Devor, M., The pathophysiology of damaged peripheral nerves (1994) Textbook of Pain, pp. 79-100. , P.D. Wall, & R. Melzack. Edinburgh: Churchill LivingstoneLane, D.A., Lindahl, U., (1989) Heparin: Chemical and Biological Properties, Clinical Application, , London: Edward ArnoldDíaz, C., Gutiérrez, J.M., Lomonte, B., Núñez, J., P-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities (1993) Toxicon, 31 (9), pp. 1202-1206Díaz-Oreiro, C., Gutiérrez, J.M., Chemical modification of histidine and lysine residues of myotoxic phospholipases A2 isolated from Bothrops asper and Bothrops godmani snake venoms: Effects on enzymatic and pharmacological properties (1997) Toxicon, 35 (2), pp. 241-252Dickenson, A.H., Sullivan, A.F., Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation (1987) Neuropharmacology, 26, pp. 1235-1238Dinarello, C.A., Cytokines as mediators in the pathogenesis of septic shock (1996) Curr. Top. Microbiol. Immunol., 216, pp. 133-165Douglas, W.W., Polypeptides-angiotensin, plasma kinins, and others vasoactive agentsProstaglandins (1970) The Pharmacological Basis of Therapeutics Fourth Ed., pp. 663-676. , L.S. Goodman, & A. Gilman. London: Coller MacmillanDray, A., Inflammatory mediators of pain (1995) Br. J. Anaesth., 75, pp. 125-131Dray, A., The pharmacology of pain (1997) Handbook of Experimental Pharmacology, pp. 21-41. , A. Dickenson, & J.-M. Besson. Berlin: SpringerDray, A., Perkins, M., Bradykinin and inflammatory pain (1993) Trends Neurosci., 16, pp. 99-104Dray, A., Urban, L., Dickenson, A., Pharmacology of chronic pain (1994) TIPS, 15, pp. 190-197Levine, J.D., Field, H.L., Basbaum, A.I., Peptides and the primary afferent nociceptor (1993) J. Neurosci., 13, pp. 2273-2286Dua, R., Cho, W., Inhibition of human secretory class II phospholipase A2 by heparin (1994) Eur. J. Biochem., 221, pp. 481-490England, S., Bevian, S., Dougherty, R.J., PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase a cascade (1996) J. Physiol. (Lond.), 495, pp. 429-440Ennis, M., Pearce, F.L., Weston, P.M., Some studies on the release of histamine from mast cells stimulated with polylysine (1980) Br. J. Pharmacol., 70 (2), pp. 329-334Erspamer, V., Half a century of comparative research on biogenic amines and active peptides in amphibian skin and molluscan tissues (1984) Comp. Biochem. Physiol., 79, pp. 1-7Farmer, S.G., Burch, R.M., Biochemical and molecular pharmacology of kinin receptors (1992) Annu. Rev. Pharmacol. Toxicol., 32, pp. 511-536Ferreira, S.H., Lorenzetti, B.B., Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception (1995) Neuropharmacology, 33, p. 1479Ferreira, S.H., Nakamura, M., I, Prostaglandin hyperalgesia, a cAMP/Ca2+dependent process (1979) Prostaglandins, 18, pp. 179-190Ferreira, S.H., Lorenzetti, B.B., Poole, S., Bradykinin initiates cytokine-mediated inflammatory hyperalgesia (1993) Br. J. Pharmacol., 110, pp. 1227-1231Fitzgerald, E.M., Okuse, K., Wood, J.N., Dolphin, A.C., Moss, S.J., CAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS (1999) J. Physiol., 516 (PT 2), pp. 433-446Fock, S., Mense, S., Excitatory effects of 5-hydroxytryptamine, histamine and potassium ions on muscular group IV afferent units: A comparison with bradykinin (1976) Brain Res., 105, pp. 459-469Lin, Y.H., Lee, S.C., Chang, P.Y., Rajan, P.K., Sue, S.C., Wu, W.G., Heparin binding to cobra basic phospholipase A2 depends on heparin chain length and amino acid specificity (1999) FEBS Lett., 453 (3), pp. 395-399Foley, K.M., Inturrisi, C.E., Analgesic drug therapy in cancer pain: Principles and practice (1987) Med. Clin. North. Am., 71, pp. 207-232Ford-Hutchinson, A.W., Leukotriene B4 in inflammation (1990) Crit. Rev. Immunol., 10, pp. 1-12Francis, B., Gutiérrez, J.M., Lomonte, B., Kaiser, I.I., Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2 (1991) Arch. Biochem. Biophys., 284 (2), pp. 352-359Franson, R.C., Saal, J.S., Saal, J.A., Human disc phospholipase A2 is inflammatory (1992) Spine, 17, pp. 129-S132Fu, Y., Light, A.R., Matsushima, G.K., Maixner, W., Microglial reactions after subcutaneous formalin injection into the rat hind paw (1999) Brain Res., 825, pp. 59-67Gambero, A., Landucci, E.C., Toyama, M.H., Marangoni, S., Giglio, J.R., Nader, H.B., Dietrich, C.P., Antunes, E., Human neutrophil migration in vitro induced by secretory phospholipases A2: A role for cell surface glycosaminoglycans (2002) Biochem. Pharmacol., 63 (1), pp. 65-72Gammon, C.M., Allen, A.C., Morell, P., Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons (1989) J. Neurochem., 53, pp. 95-101Garcia-Leme, J., Hammamura, L., Leite, M.P., Rocha Silva, E.M., Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating (1973) Br. J. Pharmacol., 48, pp. 88-96Garrison, C.J., Dougherty, P.M., Kajander, K.C., Carlton, S.M., Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury (1991) Brain Res., 565, pp. 1-7Geoghegan, P., Angulo, Y., Cangelosi, A., Díaz, M., Lomonte, B., Characterization of a basic phospholipase A2-homologue myotoxin isolated from the venom of the snake Bothrops neuwiedii (yarara chica) from Argentina (1999) Toxicon, 37 (12), pp. 1735-1746Lloret, S., Moreno, J.J., Oedema formation and degranulation of mast cells by phospholipase A 2 purified from porcine pancreas and snake venoms (1993) Toxicon, 31, pp. 949-956Gillies, G.W., Kenny, G.N., Bullingham, R.E., McArdle, C.S., The morphine sparing effect of ketorolac tromethamine. A study of a new parenteral non-steroidal anti-inflammatory agent after abdominal surgery (1987) Anaesthesia, 42, pp. 727-731Gold, M.S., Shuster, M.J., Levine, J.D., Characterization of six voltage-gated K+currents in adult rat sensory neurons (1996) J. Neurophysiol., 75, pp. 2629-2646Granger, D.N., Kubes, P., The microcirculation and inflammation: Modulation of leukocyte- endothelial cell adhesion (1994) J. Leukoc. Biol., 55, pp. 662-675Greenberg, S., Modular components of phagocytosis (1999) J. Leukoc. Biol., 66, pp. 712-717Grisham, M.B., Granger, D.N., Lefer, D.J., Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease (1998) Free Radic. Biol. Med., 25, pp. 404-433Gronblad, M., Virri, J., Ronkko, S., Kiviranta, I., Vanharanta, H., Seitsalo, S., Rashbaum, R.F., Guyer, R.D., A controlled biochemical and immunohistochemical study of human synovial-type (group II) phospholipase A2 and inflammatory cells in macroscopically normal, degenerated, and herniated human lumbar disc tissues (1996) Spine, 21, pp. 2531-2538Gutiérrez, J.M., Lomonte, B., Phospholipase A2 myotoxins from Bothrops snake venoms (1995) Toxicon, 33 (11), pp. 1405-1424Gutiérrez, J.M., Rojas, G., Lomonte, B., Gené, J.A., Cerdas, L., Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom (1986) Comp. Biochem. Physiol., 85, pp. 171-175Han, S.K., Kim, K.P., Koduri, R., Bittova, L., Munoz, N.M., Leff, A.R., Wilton, D.C., Cho, W., Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2 (1999) J. Biol. Chem., 274 (17), pp. 11881-11881Harris, J.B., Cullen, M.J., Muscle necrosis caused by snake venoms and toxins (1990) Electron Microsci. Rev., 3, pp. 183-211Lloret, S., Moreno, J.J., Ca2+influx, phosphoinositide hydrolysis, and histamine release induced by lysophosphatidylserine in mast cells (1995) J. Cell. Physiol., 165 (1), pp. 89-95Hernández, M., Burillo, S.L., Crespo, M.S., Nieto, M.L., Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1 (1998) J. Biol. Chem., 273 (1), pp. 606-612Holguin, A., O'Connor, K.A., Hansen, M.K., Milligan, E.D., Cheepsunthorn, P., Bravmann, C., Cochran, K., Watkins, L.R., Nitric oxide mediates HIV-1 gp120-induced spinal proinflammatory cytokine production and low threshold mechanical allodynia (2002) J. Pain, 2, p. 27913Homsi-Brandeburgo, M.I., Queiroz, L.S., Santo-Neto, H., Rodrigues-Simioni, L., Giglio, J.R., Fractionation of Bothrops jararacussu snake venom: Partial chemical characterization and biological activity of bothropstoxin (1988) Toxicon, 26, pp. 615-627Huwiler, A., Staudt, G., Kramer, R.M., Pfeilschifter, J., Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells (1997) Biochim. Biophys. Acta, 1348 (3), pp. 257-272James, M.J., Penglis, P.S., Caughey, G.E., Demasi, M., Cleland, L.G., Eicosanoid production by human manocytes: Does COX-2 contribute to a self-lomoting inflammatory response? (2001) Inflamm. Res., 50, pp. 249-253Joris, I., Majno, G., Corey, E.J., Lewis, R.A., The mechanisms of vascular leakage induced by leukotriene E4: Endothelial contraction (1987) Am. J. Pathol., 126, pp. 19-24Kanashiro, M.M., De Cassia, M., Escocard, R., Petretski, J.H., Prates, M.V., Alves, E.W., MacHado, O.L., Kipnis, T.L., Biochemical and biological properties of phospholipases A2 from Bothrops atrox snake venom (2002) Biochem. Pharmacol., 64 (7), pp. 1179-1186Khasar, S.G., Miao, F.J., Levine, J.D., Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat (1995) Neuroscience, 69, pp. 685-690Kidd, B.L., Urban, L.A., Mechanisms of inflammatory pain (2001) Br. J. Anaesth., 87, pp. 3-11Kim, K.P., Rafter, J.D., Bittova, L., Han, S.K., Snitko, Y., Munoz, N.M., Leff, A.R., Cho, W., Mechanism of human group V phospholipase A2 (PLA 2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation (2001) J. Biol. Chem., 276 (14), pp. 11126-11134Lomonte, B., Gutiérrez, J.M., A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo) (1989) Toxicon, 27, pp. 725-733Kim, Y.J., Kim, K.P., Han, S.K., Munoz, N.M., Zhu, X., Sano, H., Leff, A.R., Cho, W., Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A 2 (2002) J. Biol. Chem., 277 (39), pp. 36479-36488King, A.E., Thompson, S.W., Urban, L., Woolf, C.J., An intracellular analysis of amino acid induced excitations of deep dorsal horn neurones in the rat spinal cord slice (1988) Neurosci. Lett., 89, pp. 286-292Kini, R.M., Evans, H.J., A model to explain the pharmacological effects of snake venom phospholipases A2 (1989) Toxicon, 27 (6), pp. 613-635Kyger, E.M., Franson, R.C., Nonspecific inhibition of enzymes by p-bromophenacyl bromide. Inhibition of human platelet phospholipase C and modification of sulfhydryl groups (1984) Biochim. Biophys. Acta, 794 (1), pp. 96-103Lam, B.K., Gagnon, L., Austen, K.F., Soberman, R.J., The mechanism of leukotriene B4 export from human polymorphonuclear leucocytes (1990) J. Biol. Chem., 265 (23), pp. 13438-13441Landucci, E.C., Castro, R.C., Pereira, M.F., Cintra, A.C., Giglio, J.R., Marangoni, S., Oliveira, B., De Nucci, G., Mast cell degranulation induced by two phospholipase A2 homologues: Dissociation between enzymatic and biological activities (1998) Eur. J. Pharmacol., 343 (2-3), pp. 257-263Landucci, E.C., Toyama, M., Marangoni, S., Oliveira, B., Cirino, G., Antunes, E., De Nucci, G., Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2 (2000) Toxicon, 38 (2), pp. 199-208Landucci, E.C., De Castro, R.C., Toyama, M., Giglio, J.R., Marangoni, S., De Nucci, G., Antunes, E., Inflammatory oedema induced by the Lys-49 phospholipase A2 homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide (2000) Biochem. Pharmacol., 59 (10), pp. 1289-1294Lomonte, B., Tarkowski, A., Hanson, L.A., Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model (1993) Inflammation, 17 (2), pp. 93-105Lomonte, B., Tarkowski, A., Bagge, U., Harson, L.A., Neutralization of the cytosolic and myotoxic activities of phospholipase A2 from Bothrops asper snake venom by glycosaminoglycans of heparin/heparan sulfate family (1994) Biochem. Pharmacol., 47, pp. 1509-1518Lomonte, B., Moreno, E., Tarkowski, A., Hanson, L.A., MacCarana, M., Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling (1994) J. Biol. Chem., 269 (47), pp. 29867-29873Luster, A.D., Chemokines: Chemotactic cytokines that mediate inflammation (1998) N. Engl. J. Med., 338, pp. 436-445Besson, J.M., The neurobiology of pain (1999) Lancet, 353, pp. 1610-1615Malmstrom, K., Daniels, S., Kotey, P., Seidenberg, B.C., Desjardins, P.J., Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator- controlled clinical trial (1999) Clin. Ther., 21, pp. 1653-1663Mancuso, L.C., Correa, M.M., Vieira, C.A., Cunha, O.A.B., Lachat, J.J., Selistre, H.S.A., Ownby, C.L., Giglio, J.R., Fractionation of Bothrops pirajai snake venom: Isolation and characterization of piratoxin-I, a new myotoxic protein (1995) Toxicon, 33, pp. 615-626Marshall, L.A., Bolognese, B., Roshak, A., Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation (1999) Adv. Exp. Med. Biol., 469, pp. 215-219Marshall, J., Krump, E., Lindsay, T., Downey, G., Ford, D.A., Zhu, P., Walker, P., Rubin, B., Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils (2000) J. Immunol., 164 (4), pp. 2084-2091Matzner, O., Devor, M., Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+channels (1994) J. Neurophysiol., 72, pp. 349-359McLean, P.G., Ahluwalia, A., Perretti, M., Association between kinin B1 receptor expression and leukocyte trafficking across mouse mesenteric post-capillary venules (2000) J. Exp. Med., 192, pp. 367-380McMahon, S.B., Lewin, G.R., Wall, P.D., Central hyperexcitability triggered by noxious inputs (1993) Curr. Opin. Neurobiol., 3, pp. 602-610Meller, S.T., Thermal and mechanical hyperalgesia. A distinct role for different excitatory amino acid receptors and signal transduction pathways? (1994) APS J., 3, pp. 215-231Melo, P.A., Ownby, C.L., Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA 2 myotoxins (1999) Toxicon, 37 (1), pp. 199-215Melo, P.A., Homsi-Brandenburgo, M.I., Giglio, J.R., Suarez-Kurtz, G., Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions (1993) Toxicon, 31, pp. 285-291